Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Clinical trial NCT06979531 · RECRUITING
Trial details
- NCT number
- NCT06979531
- Sponsor
- Immunovant Sciences GmbH
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2028-07-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.